How do you add and titrate epinephrine (adrenaline) in a patient already on levophed (norepinephrine) at 20 micrograms (mcg)/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adding Epinephrine to High-Dose Norepinephrine

When a patient is already on norepinephrine 20 mcg/min (approximately 0.3 mcg/kg/min in a 70 kg adult) and requires additional vasopressor support, add epinephrine at 2-10 mcg/min (0.03-0.15 mcg/kg/min) as a continuous IV infusion, preferably through central venous access. 1, 2

Initial Epinephrine Dosing Strategy

Starting Dose

  • Begin epinephrine at 2-5 mcg/min (0.03-0.07 mcg/kg/min) as a continuous IV infusion 1, 2
  • Prepare a standard concentration by adding 1 mg epinephrine to 250 mL D5W, yielding 4 mcg/mL 2
  • Administer through central venous access whenever possible to minimize extravasation risk 2, 3

Titration Protocol

  • Increase epinephrine by 2-5 mcg/min increments every 5-10 minutes based on blood pressure response and tissue perfusion markers 1, 2
  • Target mean arterial pressure (MAP) ≥65 mmHg 2, 3
  • Maximum recommended dose is 10 mcg/min for standard vasopressor support 1
  • For refractory shock, doses up to 0.5 mcg/kg/min may be necessary 1

Monitoring Requirements During Dual Vasopressor Therapy

Hemodynamic Parameters

  • Monitor blood pressure every 5-15 minutes during initial titration 2
  • Place an arterial catheter for continuous blood pressure monitoring if not already present 2, 3
  • Assess heart rate continuously, as epinephrine causes more tachycardia than norepinephrine alone 3

Tissue Perfusion Markers

  • Evaluate lactate clearance, urine output (target >50 mL/h), mental status, and capillary refill 2, 3
  • Monitor for signs of excessive vasoconstriction: cold extremities, decreased urine output, rising lactate 2
  • Assess for myocardial ischemia, particularly in patients with coronary artery disease, as epinephrine increases myocardial oxygen consumption 1, 3

Critical Considerations When Combining Vasopressors

Volume Status

  • Ensure adequate fluid resuscitation (minimum 30 mL/kg crystalloid) before escalating vasopressors, as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure 2, 3
  • Continue crystalloid boluses (500-1000 mL) if signs of ongoing hypovolemia persist 1

Alternative Escalation Strategy

  • Consider adding vasopressin 0.03-0.04 units/min instead of epinephrine when norepinephrine reaches 0.25 mcg/kg/min 2, 3
  • Vasopressin may be preferred over epinephrine as it does not increase heart rate or myocardial oxygen demand 2
  • If vasopressin is already on board, then epinephrine becomes the appropriate third agent 2

Inotropic Support Consideration

  • If persistent hypoperfusion exists despite adequate MAP (suggesting myocardial dysfunction), add dobutamine 2.5-20 mcg/kg/min rather than escalating epinephrine 2
  • Dobutamine provides inotropic support without the excessive vasoconstriction of high-dose catecholamines 2

Practical Administration Details

Preparation for Refractory Cases

  • For anaphylaxis or refractory shock requiring higher doses, prepare a more concentrated solution: 1 mg epinephrine in 100 mL saline (10 mcg/mL) 2, 4
  • This allows administration at 30-100 mL/h (5-15 mcg/min) for easier titration 2

Extravasation Management

  • If extravasation occurs, immediately infiltrate phentolamine 5-10 mg diluted in 10-15 mL saline into the affected site to prevent tissue necrosis 2, 3
  • Epinephrine causes severe tissue necrosis similar to norepinephrine 2

Common Pitfalls to Avoid

Inadequate Volume Resuscitation

  • Never escalate to dual vasopressors without ensuring adequate intravascular volume, as this creates a "high pressure, low flow" state that worsens organ perfusion 2, 3
  • The most common error is adding epinephrine when the patient actually needs more fluid 2

Excessive Tachycardia

  • Epinephrine has stronger beta-1 effects than norepinephrine, causing significant tachycardia that increases myocardial oxygen demand 3, 5
  • If heart rate exceeds 120-130 bpm, consider switching to vasopressin or phenylephrine instead 2, 3

Ignoring Tissue Perfusion

  • Do not titrate solely to MAP targets—assess lactate clearance, urine output, mental status, and capillary refill 2, 3
  • High doses of catecholamines can maintain blood pressure while worsening microcirculatory flow, particularly in the gastrointestinal tract 6

Drug Incompatibility

  • Never mix epinephrine or norepinephrine with sodium bicarbonate or other alkaline solutions, as catecholamines are inactivated in alkaline environments 2

Special Clinical Scenarios

Perioperative Anaphylaxis

  • In Grade III anaphylaxis (life-threatening hypotension/bronchospasm) unresponsive to other vasopressors, start epinephrine at 100 mcg IV bolus, then transition to infusion at 0.05-0.1 mcg/kg/min 1
  • For persistent hypotension after 10 minutes, add norepinephrine infusion (0.05-0.5 mcg/kg/min) rather than escalating epinephrine alone 1

Beta-Blocker Toxicity

  • Norepinephrine is more effective than dopamine for hypotension in beta-blocker toxicity 2
  • Add glucagon 1-2 mg IV with infusion of 3-5 mg/h if hypotension persists despite catecholamines 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anaphylaxis Management with Epinephrine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.